Company Filing History:
3 out of 48 
2 out of 66 
2 out of 846 
Years Active: 2014-2024
Title: **Daniela Parolaro: Innovating Treatments for Autism Spectrum Disorder**
Introduction
Daniela Parolaro, an accomplished inventor based in Varese, Italy, has made significant contributions to the field of medical research with a focus on autism spectrum disorder (ASD) and related conditions. With a total of five patents to her name, she has dedicated her career to discovering innovative treatments that leverage the potential of phytochemicals.
Latest Patents
Parolaro's most recent patents include groundbreaking research on the application of cannabidiolic acid (CBDA) and cannabidivarin (CBDV). The patent for **Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders** outlines the effectiveness of CBDA in improving cognitive dysfunction associated with ASD, Fragile X syndrome, Rett syndrome, and Angelman syndrome. This invention stipulates that the CBDA utilized should be of high purity, ensuring that at least 95% of the extract comprises this potent cannabinoid.
Additionally, her patent titled **Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia** presents CBDV as a treatment for cognitive dysfunction related to ASD and schizophrenia. This invention, too, emphasizes the use of highly purified CBDV, making significant headway in therapeutic approaches for cognitive impairments.
Career Highlights
Throughout her career, Daniela has worked with prominent organizations such as GW Research Limited and GW Pharma Limited, where she has contributed her expertise in cannabinoid research. Her work focuses on enhancing the understanding of how these compounds can impact neurological disorders, particularly in improving the quality of life for those affected by ASD and related disorders.
Collaborations
Daniela Parolaro has collaborated with notable colleagues, including Geoffrey W Guy and Stephen Wright. These partnerships have been instrumental in driving forward innovative research and development within the field of cannabinoid-based therapeutics.
Conclusion
With her dedication to pioneering research and her impressive track record of patents, Daniela Parolaro stands at the forefront of medical innovation. Her work not only contributes to the scientific community but also offers hope for individuals and families affected by autism spectrum disorder. As research progresses, her innovations may lead to transformative treatments that improve cognitive functioning and overall well-being for many.